244 related articles for article (PubMed ID: 23764089)
1. Vascular endothelial growth factor in Coats' disease.
Zhao Q; Peng XY; Chen FH; Zhang YP; Wang L; You QS; Jonas JB
Acta Ophthalmol; 2014 May; 92(3):e225-8. PubMed ID: 23764089
[TBL] [Abstract][Full Text] [Related]
2. Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease.
Zhang H; Liu ZL
J Ocul Pharmacol Ther; 2012 Aug; 28(4):397-401. PubMed ID: 22233441
[TBL] [Abstract][Full Text] [Related]
3. Differences in aqueous concentrations of cytokines in paediatric and adult patients with Coats' disease.
Feng J; Zheng X; Li B; Jiang Y
Acta Ophthalmol; 2017 Sep; 95(6):608-612. PubMed ID: 27364629
[TBL] [Abstract][Full Text] [Related]
4. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
He YG; Wang H; Zhao B; Lee J; Bahl D; McCluskey J
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1519-21. PubMed ID: 20379736
[TBL] [Abstract][Full Text] [Related]
5. Associations of cytokine concentrations in aqueous humour with retinal vascular abnormalities and exudation in Coats' disease.
Zhang J; Jiang C; Ruan L; Huang X
Acta Ophthalmol; 2019 May; 97(3):319-324. PubMed ID: 30414256
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor in eyes with Coats' disease.
Kase S; Rao NA; Yoshikawa H; Fukuhara J; Noda K; Kanda A; Ishida S
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):57-62. PubMed ID: 23221067
[TBL] [Abstract][Full Text] [Related]
8. iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease.
Yang Q; Lu H; Song X; Li S; Wei W
PLoS One; 2016; 11(7):e0158611. PubMed ID: 27416065
[TBL] [Abstract][Full Text] [Related]
9. Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.
Cai X; Zhao P; Zhang Q; Jin H
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):999-1004. PubMed ID: 25794987
[TBL] [Abstract][Full Text] [Related]
10. Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease.
Liang T; Xu Y; Zhu X; Zhang X; Li J; Zhao P
BMC Ophthalmol; 2020 May; 20(1):178. PubMed ID: 32370768
[TBL] [Abstract][Full Text] [Related]
11. Coats' disease diagnosed in adulthood.
Smithen LM; Brown GC; Brucker AJ; Yannuzzi LA; Klais CM; Spaide RF
Ophthalmology; 2005 Jun; 112(6):1072-8. PubMed ID: 15882905
[TBL] [Abstract][Full Text] [Related]
12. Levels of cytokines in the aqueous humor guided treatment of refractory macular edema in adult-onset coats' disease.
Wang Y; Fan H; Gao K; He W; Tao Y
BMC Ophthalmol; 2020 Jun; 20(1):261. PubMed ID: 32605612
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK
Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and interleukin-6 are correlated with serous retinal detachment in central retinal vein occlusion.
Noma H; Funatsu H; Mimura T
Curr Eye Res; 2012 Jan; 37(1):62-7. PubMed ID: 21978265
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the diagnosis and treatment of Coats' disease.
Yang X; Wang C; Su G
Int Ophthalmol; 2019 Apr; 39(4):957-970. PubMed ID: 30895419
[TBL] [Abstract][Full Text] [Related]
16. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
Bhat V; D'Souza P; Shah PK; Narendran V
Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
[TBL] [Abstract][Full Text] [Related]
17. Level of vascular endothelial growth factor 165b in human aqueous humor.
Baba T; Bikbova G; Kitahashi M; Yokouchi H; Oshitari T; Yamamoto S
Curr Eye Res; 2014 Aug; 39(8):830-6. PubMed ID: 24502617
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Drugs for Coats' Disease Treatment: A Systematic Review.
Bai J; Song Z; Li G; Dong L; Zhang C
J Ocul Pharmacol Ther; 2023 Sep; 39(7):418-429. PubMed ID: 37504967
[No Abstract] [Full Text] [Related]
19. Aqueous humor vascular endothelial growth factor in dogs: association with intraocular disease and the development of pre-iridal fibrovascular membrane.
Sandberg CA; Herring IP; Huckle WR; LeRoith T; Pickett JP; Rossmeisl JH
Vet Ophthalmol; 2012 Mar; 15 Suppl 1():21-30. PubMed ID: 22050642
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor in the aqueous humour in eyes with myopic choroidal neovascularization.
Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
Acta Ophthalmol; 2011 Aug; 89(5):459-62. PubMed ID: 20102348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
